Prospective evaluation of virulence factors of enterococci isolated from patients with peritonitis: impact on outcome

Diagnostic Microbiology and Infectious Disease

Volumn 60, Issue 3, 2008, Pages 247-253

  Dupont, Hervé ^a   Vael, Carl ^b   Muller Serieys, Claudette ^a   Chosidow, Denis ^a   Mantz, Jean ^b   Marmuse, Jean Pierre ^a   Andremont, Antoine ^a   Goossens, Hermann ^b   Desmonts, Jean Marie ^a  

^a BICHAT HOSPITAL   (France)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Enterococcus; Outcome; Peritonitis; Virulence factor

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CYTOLYSIN; GELATINASE; GENTAMICIN; KANAMYCIN; MEMBRANE PROTEIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; VIRULENCE FACTOR;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG SENSITIVITY; ENTEROCOCCUS; FEMALE; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PERITONEAL FLUID; PERITONITIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BACTERIAL PROTEINS; BACTERIOCINS; ENTEROCOCCUS; FEMALE; GELATINASES; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PERITONITIS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VIRULENCE FACTORS;

EID: 39149108127     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.10.006     Document Type: Article

References (37)

1. Alberti C., Brun-Buisson C., Burchardi H., Martin C., Goodman S., Artigas A., Sicignano A., Palazzo M., Moreno R., Boulme R., Lepage E., and Le Gall R. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 28 (2002) 525-526
2. Annane D., Sebille V., Charpentier C., Bollaert P.E., Francois B., Korach J.M., Capellier G., Cohen Y., Azoulay E., Troche G., Chaumet-Riffaut P., and Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
3. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., Steingrub J.S., Garber G.E., Helterbrand J.D., Ely E.W., and Fisher Jr. C.J. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344 (2001) 699-709
4. Burnett R.J., Haverstock D.C., Dellinger E.P., Reinhart H.H., Bohnen J.M., Rotstein O.D., Vogel S.B., and Solomkin J.S. Definition of the role of Enterococcus in intraabdominal infection: analysis of a prospective randomized trial. Surgery 118 (1995) 716-721 [discussion 721-3]
5. Coque T.M., Patterson J.E., Steckelberg J.M., and Murray B.E. Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. J. Infect. Dis. 171 (1995) 1223-1229
6. Descheemaeker P., Lammens C., Pot B., Vandamme P., and Goossens H. Evaluation of arbitrarily primed PCR analysis and pulsed-field gel electrophoresis of large genomic DNA fragments for identification of enterococci important in human medicine. Int. J. Syst. Bacteriol. 47 (1997) 555-561
7. Di Rosa R., Creti R., Venditti M., D'Amelio R., Arciola C.R., Montanaro L., and Baldassarri L. Relationship between biofilm formation, the enterococcal surface protein (Esp) and gelatinase in clinical isolates of Enterococcus faecalis and Enterococcus faecium. FEMS Microbiol. Lett. 256 (2006) 145-150
8. Dupont H., Montravers P., Mohler J., and Carbon C. Disparate findings on the role of virulence factors of Enterococcus faecalis in mouse and rat models of peritonitis. Infect. Immun. 66 (1998) 2570-2575
9. Dupont H., Paugam-Burtz C., Muller-Serieys C., Fierobe L., Chosidow D., Marmuse J.P., Mantz J., and Desmonts J.M. Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch. Surg. 137 (2002) 1341-1346
10. Dupont H., Bourichon A., Paugam-Burtz C., Mantz J., and Desmonts J.M. Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?. Crit. Care Med. 31 (2003) 752-757
11. Elsner H.A., Sobottka I., Mack D., Claussen M., Laufs R., and Wirth R. Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates. Eur. J. Clin. Microbiol. Infect. Dis. 19 (2000) 39-42
12. Fagon J.Y., Chastre J., Novara A., Medioni P., and Gibert C. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunction and/or infection. Intensive Care Med. 19 (1993) 137-144
13. Fierobe L., Decre D., Muller C., Lucet J.C., Marmuse J.P., Mantz J., and Desmonts J.M. Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: relation to nasal colonization. Clin. Infect. Dis. 29 (1999) 1231-1238
14. Galli D., Lottspeich F., and Wirth R. Sequence analysis of Enterococcus faecalis aggregation substance encoded by the sex pheromone plasmid pAD1. Mol. Microbiol. 4 (1990) 895-904
15. Gordts B., Van Landuyt H., Ieven M., Vandamme P., and Goossens H. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J. Clin. Microbiol. 33 (1995) 2842-2846
16. Huycke M.M., Spiegel C.A., and Gilmore M.S. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 35 (1991) 1626-1634
17. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit. Care Med. 13 (1985) 818-829
18. Le Gall J.R., Lemeshow S., and Saulnier F. A new simplified acute physiology score (SAPS II) based on a European-North American multicenter study. JAMA 270 (1993) 29057-29068
19. Low D.E., Keller N., Barth A., and Jones R.N. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32 Suppl 2 (2001) S133-S145
20. Marra A., Dib-Hajj F., Lamb L., Kaczmarek F., Shang W., Beckius G., Milici A.J., Medina I., and Gootz T.D. Enterococcal virulence determinants may be involved in resistance to clinical therapy. Diagn. Microbiol. Infect. Dis. 58 (2007) 59-65
21. McCabe W.R., and Jackson G.G. Gram negative bacteremia, etiology and ecology. Arch. Intern. Med. 110 (1962) 845
22. Mohamed J.A., Huang W., Nallapareddy S.R., Teng F., and Murray B.E. Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. Infect. Immun. 72 (2004) 3658-3663
23. Montravers P., Gauzit R., Muller C., Marmuse J.P., Fichelle A., and Desmonts J.M. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin. Infect. Dis. 23 (1996) 486-494
24. Mosdell D.M., Morris D.M., Voltura A., Pitcher D.E., Twiest M.W., Milne R.L., Miscall B.G., and Fry D.E. Antibiotic treatment for surgical peritonitis. Ann. Surg. 214 (1991) 543-549
25. Nathens A.B., Rotstein O.D., and Marshall J.C. Tertiary peritonitis: clinical features of a complex nosocomial infection. World J. Surg. 22 (1998) 158-163
26. Qin X., Singh K.V., Weinstock G.M., and Murray B.E. Characterization of fsr, a regulator controlling expression of gelatinase and serine protease in Enterococcus faecalis OG1RF. J. Bacteriol. 183 (2001) 3372-3382
27. Raad I.I., Hanna H.A., Boktour M., Chaiban G., Hachem R.Y., Dvorak T., Lewis R., and Murray B.E. Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm. Antimicrob. Agents Chemother. 49 (2005) 5046-5050
28. Roehrborn A., Thomas L., Potreck O., Ebener C., Ohmann C., Goretzki P.E., and Röher H.D. The microbiology of postoperative peritonitis. Clin. Infect. Dis. 33 (2001) 1513-1519
29. Shankar V., Baghdayan A.S., Huycke M.M., Lindahl G., and Gilmore M.S. Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect. Immun. 67 (1999) 193-200
30. Sitges-Serra A., Lopez M.J., Girvent M., Almirall S., and Sancho S.S. Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br. J. Surg. 89 (2002) 361-367
31. Sotto A., Lefrant J.Y., Fabbro-Peray P., Muller L., Tafuri J., Navarro F., Prudhomme M., and De La Coussaye J.E. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J. Antimicrob. Chemother. 50 (2002) 569-576
32. Soussy C.J., Carret G., Cavallo J.D., Chardon H., Chidiac C., Choutet P., Courvalin P., Dabernat H., Drugeon H., Dubreuil L., Goldstein F., Jarlier V., Leclercq R., Nicolas-Chanoine M.H., Philippon A., Quentin C., Rouveix B., and Sirot J. Antibiogram Committee of the French Microbiology Society. Report 2000-2001. Pathol. Biol. (Paris) 48 (2000) 832-871
33. Su Y.A., Sulavik M.C., He P., Makinen K.K., Makinen P.L., Fiedler S., Wirth R., and Clewell D.B. Nucleotide sequence of the gelatinase gene (gelE) from Enterococcus faecalis subs. liquefaciens. Infect. Immun. 59 (1991) 415-420
34. van der Meer J.T., Thompson J., Valkenburg H.A., and Michel M.F. Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics. Arch. Intern. Med. 152 (1992) 1863-1868
35. Vergis E.N., Shankar N., Chow J.W., Hayden M.K., Snydman D.R., Zervos M.J., Linden P.K., Wagener M.M., and Muder R.R. Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis. Clin. Infect. Dis. 35 (2002) 570-575
36. Waar K., Muscholl-Silberhorn A.B., Willems R.J., Slooff M.J., Harmsen H.J., and Degener J.E. Genogrouping and incidence of virulence factors of Enterococcus faecalis in liver transplant patients differ from blood culture and fecal isolates. J. Infect. Dis. 185 (2002) 1121-1127
37. Willems R.J., Homan W., Top J., van Santen-Verheuvel M., Tribe D., Manzioros X., Gaillard C., Vandenbroucke-Grauls C.M., Mascini E.M., van Kregten E., van Embden J.D., and Bonten M.J. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357 (2001) 853-855